Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.
Biomarkers
Child
Cytokines
/ genetics
Disease Susceptibility
Epstein-Barr Virus Infections
/ complications
Female
Gene Expression Regulation, Neoplastic
Herpesvirus 4, Human
/ immunology
High-Throughput Nucleotide Sequencing
Hodgkin Disease
/ diagnosis
Humans
Immunity, Innate
Killer Cells, Natural
/ immunology
Lymphocyte Activation
/ genetics
Male
Signal Transduction
Transcriptome
Epstein Barr virus
Hodgkin Lymphoma
Hyporesponsive NK cells
Infectious mononucleosis
Natural Killer cells
Next generation sequencing
RNA sequencing
Transcriptome
Journal
Immunobiology
ISSN: 1878-3279
Titre abrégé: Immunobiology
Pays: Netherlands
ID NLM: 8002742
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
13
12
2019
revised:
09
01
2020
accepted:
25
01
2020
pubmed:
12
2
2020
medline:
7
8
2021
entrez:
12
2
2020
Statut:
ppublish
Résumé
Epstein Barr Viral infection is a common childhood infection in India and is also nearly 100 % etiologically associated with pediatric Hodgkin Lymphoma (HL). The main question in EBV immunobiology has been, why only a small subset of infected individuals develop EBV associated malignancies, while the vast majority carry this virus asymptomatically for life. Natural Killer (NK) cells, with a phenotype of CD56dim CD16+ exhibit potent cytotoxicity towards both virus infected cells and transformed cells and hence have been considered to be crucial in preventing the development of symptomatic EBV infection and lymphoma. In order to get an insight into the various possible molecular aspects of NK cells, in the pathogenesis of both these EBV mediated diseases in children we studied the whole transcriptome of MACS sorted CD56dim CD16 + NK cells from four patients from each of the three groups of children viz. Infectious Mononucleosis (IM), HL and age matched controls by using a massively parallel sequencing approach. NK cells from both IM and HL had down-regulated innate immunity and chemokine signaling genes. While down-regulation of genes responsible for polarization of the secretory apparatus, activated NK cell signaling and MAP kinase signaling were exclusive to NK cells in patients with IM, in NK cells of HL, specifically, genes involved in extracellular matrix (ECM) - receptor interaction, cytokine-cytokine receptor interaction, TNF signaling, Toll-like receptor signaling pathway and cytosolic DNA-sensing pathways were significantly down-regulated. Enrichment analysis showed STAT3 to be the most significant transcription factor (TF) for the down-regulated genes in IM, whereas, GATA1 was found to be the most significant TF for the genes down-regulated in HL. Analysis of protein interaction network identified functionally important protein clusters. Top clusters, comprised of down-regulated genes, involved in signaling and ubiquitin-related processes and pathways. These may perhaps be responsible for the hypo-responsiveness of NK cells in both diseases. These possibly point to different deficiencies in NK cell activation, loss of activating receptor signaling and degranulation in IM, versus loss of cytokine and chemokine signaling in HL, in the two EBV associated pathologies investigated. Various suppressed molecules and pathways were novel, which have not been reported earlier and could therefore be potential targets for immunotherapy of NK cell reactivation in both the diseases in future.
Identifiants
pubmed: 32044149
pii: S0171-2985(19)30417-6
doi: 10.1016/j.imbio.2020.151907
pii:
doi:
Substances chimiques
Biomarkers
0
Cytokines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
151907Informations de copyright
Copyright © 2020 Elsevier GmbH. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest AKK was also the founder director of a private limited company, Shodhaka Life Sciences Pvt. Ltd., during the research period, and DS was an employee of that company. Anup Chugani, Vishnu Priya R are employees of a private company Medgenome. Declaration of interest for other authors – none.